USD 46.85
(-4.13%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.78 Billion USD | 10.96% |
2022 | 1.6 Billion USD | -26.97% |
2021 | 2.2 Billion USD | -2.96% |
2020 | 2.27 Billion USD | 136.02% |
2019 | 962.53 Million USD | 63.86% |
2018 | 587.4 Million USD | 71.29% |
2017 | 342.93 Million USD | 194.2% |
2016 | 116.56 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.7 Billion USD | -4.58% |
2024 Q2 | 1.6 Billion USD | -5.59% |
2023 Q4 | 1.78 Billion USD | -0.6% |
2023 FY | 1.78 Billion USD | 10.96% |
2023 Q2 | 1.84 Billion USD | 21.72% |
2023 Q1 | 1.51 Billion USD | -6.11% |
2023 Q3 | 1.79 Billion USD | -2.33% |
2022 Q2 | 1.85 Billion USD | -12.95% |
2022 Q4 | 1.6 Billion USD | -5.39% |
2022 FY | 1.6 Billion USD | -26.97% |
2022 Q1 | 2.12 Billion USD | -3.4% |
2022 Q3 | 1.7 Billion USD | -8.2% |
2021 Q2 | 2.29 Billion USD | -2.34% |
2021 FY | 2.2 Billion USD | -2.96% |
2021 Q1 | 2.34 Billion USD | 3.3% |
2021 Q4 | 2.2 Billion USD | -0.95% |
2021 Q3 | 2.22 Billion USD | -2.9% |
2020 Q4 | 2.27 Billion USD | 80.0% |
2020 Q1 | 948.16 Million USD | -1.49% |
2020 Q2 | 1.27 Billion USD | 34.74% |
2020 FY | 2.27 Billion USD | 136.02% |
2020 Q3 | 1.26 Billion USD | -1.21% |
2019 Q4 | 962.53 Million USD | 1.5% |
2019 Q3 | 948.33 Million USD | 0.89% |
2019 Q2 | 939.98 Million USD | 62.3% |
2019 Q1 | 579.17 Million USD | -1.4% |
2019 FY | 962.53 Million USD | 63.86% |
2018 Q4 | 587.4 Million USD | 70.46% |
2018 FY | 587.4 Million USD | 71.29% |
2018 Q1 | - USD | -100.0% |
2018 Q2 | 362.84 Million USD | 0.0% |
2018 Q3 | 344.59 Million USD | -5.03% |
2017 Q4 | 342.93 Million USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | 342.93 Million USD | 194.2% |
2016 FY | 116.56 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aclaris Therapeutics, Inc. | 197.4 Million USD | -804.952% |
Biodesix, Inc. | 99.09 Million USD | -1702.718% |
bioAffinity Technologies, Inc. | 8.22 Million USD | -21628.513% |
Castle Biosciences, Inc. | 477.81 Million USD | -273.876% |
DarioHealth Corp. | 96.38 Million USD | -1753.345% |
Exact Sciences Corporation | 6.47 Billion USD | 72.395% |
IDEXX Laboratories, Inc. | 3.25 Billion USD | 45.201% |
Illumina, Inc. | 10.11 Billion USD | 82.332% |
Intelligent Bio Solutions Inc. | 13.77 Million USD | -12864.938% |
iSpecimen Inc. | 15.81 Million USD | -11192.784% |
Standard BioTools Inc. | 323.06 Million USD | -452.957% |
23andMe Holding Co. | 395.16 Million USD | -352.067% |
Medpace Holdings, Inc. | 1.65 Billion USD | -7.822% |
NeoGenomics, Inc. | 1.68 Billion USD | -6.257% |
Inotiv, Inc. | 856.53 Million USD | -108.565% |
Psychemedics Corporation | 13.27 Million USD | -13362.102% |
Prenetics Global Limited | 254.17 Million USD | -602.844% |
Precipio, Inc. | 18.1 Million USD | -9769.184% |
RadNet, Inc. | 2.88 Billion USD | 38.115% |
Sotera Health Company | 3.13 Billion USD | 42.934% |
Star Equity Holdings, Inc. | 86.97 Million USD | -1953.971% |
Exagen Inc. | 56.94 Million USD | -3037.154% |
Natera, Inc. | 1.45 Billion USD | -22.599% |
Aspira Women's Health Inc. | 6.26 Million USD | -28427.962% |
Neogen Corporation | 4.58 Billion USD | 61.031% |
Myriad Genetics, Inc. | 1.19 Billion USD | -49.03% |
ICON Public Limited Company | 16.98 Billion USD | 89.485% |
Bionano Genomics, Inc. | 214.4 Million USD | -733.203% |
CareDx, Inc | 484.61 Million USD | -268.627% |
Check-Cap Ltd. | 25.01 Million USD | -7040.828% |
Twist Bioscience Corporation | 776.4 Million USD | -130.089% |
BioNexus Gene Lab Corp. | 11.39 Million USD | -15570.644% |
Fulgent Genetics, Inc. | 1.27 Billion USD | -40.32% |
Sera Prognostics, Inc. | 95.44 Million USD | -1771.754% |
OPKO Health, Inc. | 2.01 Billion USD | 11.198% |
Personalis, Inc. | 225.09 Million USD | -693.616% |
Applied DNA Sciences, Inc. | 13.65 Million USD | -12985.822% |
Star Equity Holdings, Inc. | 86.97 Million USD | -1953.971% |
MDxHealth SA | 129.13 Million USD | -1283.407% |
Prenetics Global Limited | 254.17 Million USD | -602.844% |
ENDRA Life Sciences Inc. | 6.75 Million USD | -26349.251% |
Mainz Biomed B.V. | 15.4 Million USD | -11493.34% |
Trinity Biotech plc | 59.43 Million USD | -2905.672% |
Neuronetics, Inc. | 115.83 Million USD | -1442.265% |
bioAffinity Technologies, Inc. | 8.22 Million USD | -21628.513% |